Next Generation Vaccine Biomarkers workshop October 30-31, 2014--Ottawa, Canada. - Wikidata - wikimedia - TriplyDB

Next Generation Vaccine Biomarkers workshop October 30-31, 2014--Ottawa, Canada.

Next Generation Vaccine Biomarkers workshop October 30-31, 2014--Ottawa, Canada.

http://www.wikidata.org/entity/Q37320156

about

Next Generation Vaccine Biomarkers workshop October 30-31, 2014--Ottawa, Canada.

http://www.wikidata.org/entity/Q37320156

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 18 September 2015

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Next Generation Vaccine Biomarkers workshop October 30-31, 2014--Ottawa, Canada.

@en

Next Generation Vaccine Biomarkers workshop October 30-31, 2014--Ottawa, Canada.

@nl

type

label

Next Generation Vaccine Biomarkers workshop October 30-31, 2014--Ottawa, Canada.

@en

Next Generation Vaccine Biomarkers workshop October 30-31, 2014--Ottawa, Canada.

@nl

prefLabel

Next Generation Vaccine Biomarkers workshop October 30-31, 2014--Ottawa, Canada.

@en

Next Generation Vaccine Biomarkers workshop October 30-31, 2014--Ottawa, Canada.

@nl

P1433

Q37320156-1CC8E8E5-98E4-41CD-AA2B-E7633C200B5F

P1476

Q37320156-3E77BF29-6D11-496F-9E4D-4E34423AD968

P2093

Q37320156-20B88E6C-D73B-4DF3-8186-0AF19C7CBF99

Q37320156-242DE6AF-2BB7-4325-AA54-CBB7662EF049

Q37320156-719D4060-72EA-457C-BC59-749873A347EF

Q37320156-7D201F05-502E-4DD8-8B2E-780672799013

Q37320156-7F14B061-01AC-4A30-9D98-873E77D2853E

Q37320156-9B41FE8E-0878-4FE9-8351-ECDC9B67D4FF

Q37320156-ACB68068-CB59-4D11-9154-A83E379F3BA2

Q37320156-C45A39E2-1069-4D9F-95DC-90A2ABBA3819

P2860

Q37320156-0EDC7682-5746-4C4F-9927-7B16BDD9741E

Q37320156-125BBB76-4234-428B-B57A-34B5B4496E8A

Q37320156-1F6AF6C1-502A-4FFF-9690-F5FBB4F9431A

Q37320156-25131417-CAD6-42F7-A3D9-42A6D294E320

Q37320156-2648329F-F1D6-46B6-991B-CA836EDAB86B

Q37320156-3594AB81-6F78-4429-AEA4-252AE463B538

Q37320156-3894CBB3-8E7B-4B11-829E-8AF623A19FF4

Q37320156-3B3A2041-CFE8-4C41-A5ED-59F2C7079D2A

Q37320156-40F3CCFD-B10B-4741-BAA2-7521C2B167D2

Q37320156-6106E9CC-8F0D-4ACB-8C23-D043B19A72F3

P304

Q37320156-D48A4609-0A4B-4017-9513-879BB487644C

P31

Q37320156-CC1851FE-898D-4EB5-9D64-221D876CDC76

P356

Q37320156-97A57B7A-2BCE-45AC-AE80-106838107FA4

P433

Q37320156-DDA2D3AD-27AE-4EDA-8E02-12DD817B841A

P478

Q37320156-61F0BAD8-E56B-4E54-93B4-4AB25ED0FFF2

P50

Q37320156-42E931AF-90C0-40E6-BC9D-EEC929AE488A

P577

Q37320156-8511D32C-3807-4311-A17A-ECC75B3CAF95

P698

Q37320156-98E1035F-46CB-466D-B9D3-6576CAD5C274

P921

Q37320156-286B60E8-F88E-482F-A035-FAB4183B13F6

Q37320156-88E0BEA2-9A20-42A3-89F5-D9DCB589BC69

Q37320156-EDA2369F-4D07-4DCD-B10F-C79DAAD9A255

P932

Q37320156-3C58386F-5A46-48A1-A23E-009C0349A6E3

P356

21645515.2015.1083663

P1433

Human Vaccines & Immunotherapeutics

P1476

Next Generation Vaccine Biomarkers workshop October 30-31, 2014--Ottawa, Canada.

@en

P2093

J Wayne Conlan

http://www.w3.org/2001/XMLSchema#string

James C Richards

http://www.w3.org/2001/XMLSchema#string

Jennifer F Raven

http://www.w3.org/2001/XMLSchema#string

John Spika

http://www.w3.org/2001/XMLSchema#string

Kelly M Fulton

http://www.w3.org/2001/XMLSchema#string

Lakshmi Krishnan

http://www.w3.org/2001/XMLSchema#string

Luis Barreto

http://www.w3.org/2001/XMLSchema#string

Susan M Twine

http://www.w3.org/2001/XMLSchema#string

P2860

Mucosal immunization of cynomolgus macaques with the VSVDeltaG/ZEBOVGP vaccine stimulates strong ebola GP-specific immune responses

Immune biomarkers predictive of respiratory viral infection in elderly nursing home residents.

Canadian Adjuvant Initiative Workshop, March 26-27, 2013--Ottawa, Canada

Systems vaccinology.

Selection of immunostimulant AS15 for active immunization with MAGE-A3 protein: results of a randomized phase II study of the European Organisation for Research and Treatment of Cancer Melanoma Group in Metastatic Melanoma.

Role of persistent CMV infection in configuring T cell immunity in the elderly

Ebola GP-specific monoclonal antibodies protect mice and guinea pigs from lethal Ebola virus infection

A high ratio of IC31(®) adjuvant to antigen is necessary for H4 TB vaccine immunomodulation.

Biomarkers and surrogate markers: an FDA perspective.

Combined vaccination and immunostimulatory antibodies provides durable cure of murine melanoma and induces transcriptional changes associated with positive outcome in human melanoma patients

P304

2923-2930

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/21645515.2015.1083663

http://www.w3.org/2001/XMLSchema#string

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P50

P577

2015-09-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26383909

http://www.w3.org/2001/XMLSchema#string

P921

P932

5054783

http://www.w3.org/2001/XMLSchema#string